4.8 Article

UHRF1 Overexpression Drives DNA Hypomethylation and Hepatocellular Carcinoma

Journal

CANCER CELL
Volume 25, Issue 2, Pages 196-209

Publisher

CELL PRESS
DOI: 10.1016/j.ccr.2014.01.003

Keywords

-

Funding

  1. Breast Cancer Alliance
  2. March of Dimes
  3. DFCI NCI Cancer Center [5P30CA006516-45]
  4. Sidney A. Swensrud Foundation
  5. NIH [5R01DK080789-02, 1R01DK099558, 1R01DK076986, F30DK094503, T32CA078207-14]
  6. European Commission [259744]
  7. Samuel Waxman Cancer Research Foundation
  8. Spanish National Health Institute [SAF-2010-16055]
  9. Asociacion Espanola Contra el Cancer
  10. ICREA Funding Source: Custom

Ask authors/readers for more resources

Ubiquitin-like with PHD and RING finger domains 1 (UHRF1) is an essential regulator of DNA methylation that is highly expressed in many cancers. Here, we use transgenic zebrafish, cultured cells, and human tumors to demonstrate that UHRF1 is an oncogene. UHRF1 overexpression in zebrafish hepatocytes destabilizes and delocalizes Dnmt1 and causes DNA hypomethylation and Tp53-mediated senescence. Hepatocellular carcinoma (HOC) emerges when senescence is bypassed. tp53 mutation both alleviates senescence and accelerates tumor onset. Human HCCs recapitulate this paradigm, as UHRF1 overexpression defines a subclass of aggressive HCCs characterized by genomic instability, TP53 mutation, and abrogation of the TP53-mediated senescence program. We propose that UHRF1 overexpression is a mechanism underlying DNA hypomethylation in cancer cells and that senescence is a primary means of restricting tumorigenesis due to epigenetic disruption.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available